We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
1376
DELISTED
Veradigm Inc. Common Stock
MDRX
| $4.91M | 0.01% |
367,049
-87,235
| -19% | -$1.41M |
|
|
TRTN
1377
DELISTED
Triton International Limited
TRTN
| $4.91M | 0.01% |
94,282
+2,047
| +2% | +$106K |
|
1378
Pegasystems
PEGA
$5.38B
| $4.88M | 0.01% |
76,842
-1,500
| -2% | -$99.8K |
|
1379
Shenandoah Telecom
SHEN
$746M
| $4.87M | 0.01% |
154,081
+1,446
| +0.9% | +$55K |
|
1380
Grocery Outlet
GO
$980M
| $4.85M | 0.01% |
224,664
+25
| +0% | +$719 |
|
1381
Global Net Lease
GNL
$1.95B
| $4.84M | 0.01% |
302,347
-26,686
| -8% | -$469K |
|
1382
Methode Electronics
MEI
$592M
| $4.84M | 0.01% |
115,008
-14,315
| -11% | -$657K |
|
1383
National Health Investors
NHI
$3.65B
| $4.83M | 0.01% |
90,193
-390
| -0.4% | -$24.4K |
|
1384
Park National Corp
PRK
$3.67B
| $4.82M | 0.01% |
39,506
-4,812
| -11% | -$561K |
|
|
TMX
1385
DELISTED
Terminix Global Holdings, Inc.
TMX
| $4.82M | 0.01% |
115,615
-11,608
| -9% | -$534K |
|
1386
California Resources
CRC
$4.62B
| $4.81M | 0.01% |
117,248
+1,475
| +1% | +$48.2K |
|
1387
Sally Beauty Holdings
SBH
$1.58B
| $4.76M | 0.01% |
282,544
-42,536
| -13% | -$810K |
|
1388
News Corp Class B
NWS
$17.5B
| $4.75M | 0.01% |
204,470
-22,548
| -10% | -$516K |
|
|
CHNG
1389
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $4.75M | 0.01% |
226,818
-18,226
| -7% | -$398K |
|
1390
Fulgent Genetics
FLGT
$527M
| $4.75M | 0.01% |
52,763
-4,583
| -8% | -$417K |
|
1391
TechTarget
TTGT
$278M
| $4.74M | 0.01% |
57,548
-6,738
| -10% | -$535K |
|
1392
Middlesex Water
MSEX
$1.1B
| $4.72M | 0.01% |
45,963
+23,184
| +102% | +$2.38M |
|
1393
Deluxe
DLX
$1.15B
| $4.71M | 0.01% |
131,285
-15,293
| -10% | -$621K |
|
1394
Strategic Education
STRA
$1.92B
| $4.7M | 0.01% |
66,597
-9,392
| -12% | -$700K |
|
1395
LeMaitre Vascular
LMAT
$1.86B
| $4.69M | 0.01% |
88,351
-553
| -0.6% | -$31.1K |
|
|
ADAM
1396
Adamas Trust
ADAM
$883M
| $4.69M | 0.01% |
275,040
-35,658
| -11% | -$620K |
|
1397
Central Garden & Pet Co Class A
CENTA
$2.44B
| $4.67M | 0.01% |
135,785
-17,483
| -11% | -$604K |
|
1398
Horace Mann Educators
HMN
$2.11B
| $4.67M | 0.01% |
117,396
-15,517
| -12% | -$615K |
|
1399
CorVel
CRVL
$3.19B
| $4.67M | 0.01% |
75,159
-9,708
| -11% | -$506K |
|
1400
Green Plains
GPRE
$1.03B
| $4.66M | 0.01% |
142,576
+2,372
| +2% | +$81.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.